Raptiva Related Clinical Trials
Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy [Active, not recruiting]
Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva [Terminated]
A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g [Completed]
Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes [Recruiting]
A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis [Completed]
A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies [Completed]
A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis [Completed]
Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab [Recruiting]
TRUST Study: Raptiva ® in Hand & Foot Psoriasis [Recruiting]
A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies [Completed]
Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa [Completed]
Efalizumab for Moderate to Severe Atopic Dermatitis [Completed]
ChangE From Any Systemic psoriasiS therapY to Raptiva [Recruiting]
RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization [Recruiting]
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) [Recruiting]
Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells [Not yet recruiting]
A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g [Completed]
Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids [Recruiting]
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp [Active, not recruiting]
A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy [Completed]
A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent [Recruiting]
Raptiva to Treat Sjogren's Syndrome [Recruiting]
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis [Active, not recruiting]
Efalizumab to Treat Uveitis [Recruiting]
Effect of Topical Calcipotriene/Betamethasone (Taclonex)in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva) [Recruiting]
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients [Recruiting]
Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study [Recruiting]
Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis [Not yet recruiting]
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration [Recruiting]
A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation [Not yet recruiting]
Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) [Completed]
Efalizumab in the Treatment of Alopecia, Phase II [Recruiting]
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Patients With Moderate to Severe Plaque Psoriasis [Completed]
A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies [Completed]
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet [Completed]
Efalizumab for Eczema [Active, not recruiting]
CLEAR Study: Clinical Experience Acquired With Raptiva Study [Completed]
Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis [Recruiting]
Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus [Recruiting]
Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab [Recruiting]
Islet Transplantation Using Efalizumab [Recruiting]
Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis [Completed]
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis [Completed]
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis. [Completed]
Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment [Completed]
Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus [Recruiting]
Psoriasis Longitudinal Assessment and Registry (PSOLAR) [Recruiting]
|
